Molecular basis of celiac disease

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 53-81

  Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Celiac disease; DQ2; Gluten; HLA; Peptides; T cells

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTEN; HLA ANTIGEN; PEPTIDE;

CELIAC DISEASE; DISEASE ASSOCIATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CELIAC DISEASE; HUMANS;

EID: 0034121187     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.53     Document Type: Review

References (146)

1. Trier JS. 1991. Celiac sprue. N. Engl. J. Med. 325:1709-19
2. Thorsby E. 1997. Invited anniversary review: HLA associated diseases. Hum. Immunol. 53:1-11
3. Schmitz J. 1992. Coelic disease in childhood. In Coeliac Disease, ed. MN Marsh, pp. 17-48. Oxford: Blackwell
4. Mäki M, Collin P. 1997. Coeliac disease. Lancet 349:1755-59
5. Mäki M. 1995. The humoral immune system in coeliac disease. In Coeliac Disease, ed. PD Howdle, pp. 231-49. London: Bailliére Tindall
6. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. 1997. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3:797-801
7. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D. 1998. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115: 1317-21
8. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Samesto A, Savilahti E, Collin P, Mäki M. 1998. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322-28
9. Parnell N, Ciclitira PJ. 1999. Celiac disease. Curr. Opin. Gastroenterol. 15:120-24
10. Ivarsson A, Persson LÅ, Hernell O, Ascher H, Cavell B, Danielsson L, Dannaeus A, Lindberg T, Lindquist B, Stenhammar L. 1999. The "epidemic" of coeliac disease in Swedish children. Acta Paediatr. In press
11. Marsh MN. 1992. Mucosal pathology in gluten sensitivity. In Coeliac Disease, ed. MN Marsh, pp. 136-91. Oxford: Blackwell
12. Leigh RJ, Marsh MN, Crowe P, Kelly C, Garner V, Gordon D. 1985. Studies of intestinal lymphoid tissue. IX. Dose-dependent, gluten-induced lymphoid infiltration of coeliac jejunal epithelium. Scand. J. Gastroenterol. 20:715-19
13. Wicker LS,Todd JA, Peterson LB. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200
14. Booth CC. 1970. Enterocyte in coeliac disease. Br. Med. J. 3:725-31
15. Walker-Smith J, MacDonald T. 1989. Insights provided by the study of the small intestine in the child and the foetus. Gut 30(Spec. No): 11-16
16. Moss SF, Attia L, Scholes JV, Walters JR, Holt PR. 1996. Increased small intestinal apoptosis in coeliac disease. Gut 39:811-17
17. Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC, MacDonald TT. 1998. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J. Clin. Invest. 102:1473-80
18. Scott H, Sollid LM, Fausa O, Brandtzaeg P, Thorsby E. 1987. Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand. J. Immunol. 26:563-71
19. Marley NJ, Macartney JC, Ciclitira PJ. 1987. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease. Clin. Exp. Immunol. 70:386-93
20. Scott H, Brandtzaeg P, Solheim BG, Thorsby E. 1981. Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin. Exp. Immunol. 44:233-38
21. Colombel JF, Mascart-Lemone F, Nemeth J, Vaerman JP, Dive C, Rambaud JC. 1990. Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease. Gut 31:1345-49
22. Kutlu T, Brousse N, Rambaud C, Le Deist F, Schmitz J, Cerf-Bensussan N. 1993. Numbers of T cell receptor (TCR) αβ + but not of TcR γδ + intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 34:208-14
23. Halstensen TS, Brandtzaeg P. 1993. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4 + α/β cells in the lamina propria but proliferation (Ki-67) of α/β and γ/δ cells in the epithelium. Eur. J. Immunol. 23:505-10
24. Spencer J, Isaacson PG, Diss TC, MacDonald TT. 1989. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor γ/δ heterodimer in human intestinal intraepithelial lymphocytes. Eur. J. Immunol. 19:1335-38
25. Halstensen TS, Scott H, Brandtzaeg P. 1989. Intraepithelial T cells of the TcRγδ + CD8-and Vδ1/Jδ1 + phenotypes are increased in coeliac disease. Scand. J. Immunol. 30:665-72
26. Groh V, Steinle A, Bauer S, Spies T. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279:1737-40
27. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93:12445-50
28. Lundqvist C, Melgar S, Yeung MM, Hammarström S, Hammarström ML. 1996. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J. Immunol. 157:1926-34
29. Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer AJ, Radaszkiewicz T. 1996. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am. J. Pathol. 148:1351-57
30. Halstensen TS, Farstad IN, Scott H, Fausa O, Brandtzaeg P. 1990. Intraepithelial TcRα/β + lymphocytes express CD45RO more often than the TcRγ/δ + counterparts in coeliac disease. Immunology 71:460-66
31. Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. 1994. Detection of interferon-γ mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 35:1037-41
32. Kontakou M, Przemioslo RT, Sturgess RP, Limb AG, Ciclitira PJ. 1995. Expression of tumour necrosis factor-α, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand. J. Gastroenterol. 30:456-63
33. Nilsen EM, Jahnsen FL, Lundin KEA, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P. 1998. Gluten induces an intestinal cytokine response strongly dominated by interferon-γ in patients with celiac disease. Gastroenterology 115:551-63
34. Beckett CG, Dell'Olio D, Kontakou M, Przemioslo RT, Rosen-Bronson S, Ciclitira PJ. 1996. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease. Gut 39:818-23
35. Baklien K, Fausa O, Thune PO, Gjone E. 1977. Immunoglobulins in jejunal mucosa and serum from patients with dermatitis herpetiformis. Scand. J. Gastroenterol. 12:161-68
36. Falchuk ZM, Strober W. 1974. Glutensensitive enteropathy: synthesis of antigliadin antibody in vitro. Gut 15:947-52
37. Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M. 1996. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 348:1065-67
38. Nagashima R, Maeda K, Imai Y, Takahashi T. 1996. Lamina propria macrophages in the human gastrointestinal mucosa: their distribution, immunohistological phenotype, and function. J. Histochem. Cytochem. 44:721-31
39. Sturgess RP, Macartney JC, Makgoba MW, Hung CH, Haskard DO, Ciclitira PJ. 1990. Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin. Exp. Immunol. 82:489-92
40. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R. 1999. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44:17-25
41. Ellis A. 1981. Coeliac disease: previous family studies. In The Genetics of Coeliac Disease, ed. RB McConnell, pp. 197-99. Lancaster: M TP
42. Risch N. 1987. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40:1-14
43. Petronzelli F, Bonamico M, Ferrante P, Grillo R, Mora B, Mariani P, Apollonio I, Gemme G, Mazzilli MC. 1997. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann. Hum. Genet. 61:307-17
44. Polanco I, Biemond I, van Leeuwen A, Schreuder I, Meera Khan P, Guerrero J, D'Amaro J, Vazquez C, van Rood JJ, Peña AS. 1981. Gluten sensitive enteropathy in Spain: genetic and environmental factors. In The Genetics of Coeliac Disease, ed. RB McConnell, pp. 211-31. Lancaster: MTP
45. Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF, Michalski JP. 1996. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat. Genet. 14:329-33
46. Houlston RS, Tomlinson IP, Ford D, Seal S, Marossy AM, Ferguson A, Holmes GK, Hosie KB, Howdle PD, Jewell DP, Godkin A, Kerr GD, Kumar P, Logan RF, Love AH, Johnston S, Marsh MN, Mitton S, O'Donoghue D, Roberts A, Walker-Smith JA, Stratton MF. 1997. Linkage analysis of candidate regions for coeliac disease genes. Hum. Mol. Genet. 6:1335-39
47. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S, Zavattari P, Bouguerra F, Dib C, Tosi R, Troncone R, Ventura A, Mantavoni W, Magazz, Gatti R, Lazzari R, Giunta A, Perri F, Iacono G, Cardi E, De Virgiliis S, Cataldo F, De Angelis G, Musumeci S, Ferrari R, Balli F, Bardella MT, Volta U, Catassi C, Torre G, Eliaou JF, Serre JL, Clerget-Darpoux F. 1998. Genome search in celiac disease. Am. J. Hum. Genet. 62:669-75
48. Brett PM, Yiannakou JY, Morris MA, Bronson SR, Mathew C, Curtis D, Ciclitira PJ. 1998. A pedigree-based linkage study of coeliac disease: failure to replicate previous positive findings. Ann. Hum. Genet. 62:25-32
49. Djilali-Saiah I, Schmitz J, HarfouchHammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. 1998. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43:187-89
50. Holopainen P, Arvas M, Sistonen P, Collin P, Mäki M, Partanen J. 1999. CD28/ CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 53:470-75
51. Clot F, Fulchignoni-Lataud MC, Percopo S, Bouguerra F, Babron MC, Djilali-Saiah I, Caillat-Zucman S, Clerget-Darpoux F, Greco L, Serre JL. 1999. Linkage and association study of CTLA-4 region in coeliac disease for Italian and Tunisian populations. Tissue Antigens. In press
52. Falchuk ZM, Rogentine GN, Strober W. 1972. Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J. Clin. Invest. 51:1602-5
53. Stokes PL, Asquith P, Holmes GK, Mackintosh P, Cooke WT. 1972. Histocompatibility antigens associated with adult coeliac disease. Lancet 2:162-64
54. Keuning JJ, Pena AS, van Leeuwen A, van Hooff JP, van Rood JJ. 1976. HLA-DW3 associated with coeliac disease. Lancet 1:506-8
55. Solheim BG, Ek J, Thune PO, Baklien K, Bratlie A, Rankin B, Thoresen AB, Thorsby E. 1976. HLA antigens in dermatitis herpetiformis and coeliac disease. Tissue Antigens 7:57-59
56. Tosi R, Vismara D, Tanigaki N, Ferrara GB, Cicimarra F, Buffolano W, Folio D, Auricchio S. 1983. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin. Immunol. Immunopathol. 28:395-404
57. Alper CA, Fleischnick E, Awdeh Z, Katz AJ, Yunis EJ. 1987. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J. Clin. Invest. 79:251-56
58. Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, et al. 1992. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 39:78-83
59. DeMarchi M, Borelli I, Olivetti E, Richiardi P, Wright P, Ansaldi N, Barbera C, Santini B. 1979. Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens 14:309-16
60. Betuel H, Gebuhrer L, Descos L, Percebois H, Minaire Y, Bertrand J. 1980. Adult celiac disease associated with HLA-DRw3 and -DRw7. Tissue Antigens 15:231-38
61. Mearin ML, Biemond I, Pena AS, Polanco I, Vazquez C, Schreuder GT, de Vries RR, van Rood JJ. 1983. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 24:532-37
62. Trabace S, Giunta A, Rosso M, Marzorati D, Cascino I, Tettamanti A, Mazzilli MC, Gandini E. 1984. HLA-ABC and DR antigens in celiac disease. A study in a pediatric Italian population. Vox Sang. 46:102-6
63. Sollid LM, Thorsby E. 1993. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910-22
64. Boss JM, Strominger JL. 1984. Cloning and sequence analysis of the human major histocompatibility complex gene DC-3β. Proc. Natl Acad. Sci. USA 81:5199-5203
65. Schenning L, Larhammar D, Bill P, Wiman K, Jonsson AK, Rask L, Peterson PA. 1984. Both α and β chains of HLA-DC class n histocompatibility antigens display extensive polymorphism in their amino-terminal domains. EMBO J. 3:447-52
66. Schiffenbauer J, Didier DK, Klearman M, Rice K, Shuman S, Tieber VL, Kittlesen DJ, Schwartz BD. 1987. Complete sequence of the HLA DQα and DQβ cDNA from a DR5/DQw3 cell line. J. Immunol. 139:228-33
67. Chang HC, Moriuchi T, Silver J. 1983. The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region. Nature 305:813-15
68. Karr RW, Gregersen PK, Obata F, Goldberg D, Maccari J, Alber C, Silver J. 1986. Analysis of DRβ and DQβ chain cDNA clones from a DR7 haplotype. J. Immunol. 137:2886-90
69. Hall MA, Lanchbury JS, Lee JS, Welsh KI, Ciclitira PJ. 1993. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum. Immunol. 38:284-92
70. Carrington M. 1999. Recombination within the human MHC. Immunol. Rev. 167:245-56
71. Lin L, Jin L, Kimura A, Carrington M, Mignot E. 1997. DQ microsatellite association studies in three ethnic groups. Tissue Antigens 50:507-20
72. Lin L, Jin L, Lin X, Voros A, Underhill P, Mignot E. 1998. Microsatellite single nucleotide polymorphisms in the HLA-DQ region. Tissue Antigens 52:9-18
73. Ellis MC, Hetisimer AH, Ruddy DA, Hansen SL, Kronmal GS, McClelland E, Quintana L, Drayna DT, Aldrich MS, Mignot E. 1997. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 46:410-17
74. Sollid LM, Thorsby E. 1990. The primary association of celiac disease to a given HLA-DQ α/β heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36:136-37
75. Ploski R, Ek J, Thorsby E, Sollid LM. 1993. On the HLA-DQ(α1*0501, β1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41:173-77
76. Greenberg DA, Hodge SE, Rotter JI. 1982. Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am. J. Hum. Genet. 34:263-77
77. Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E. 1992. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum. Immunol. 35:188-92
78. Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JS, Ciclitira PJ. 1993. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum. Immunol. 38:270-76
79. Polvi A, Arranz E, Fernandez-Arquero M, Collin P, Mäki M, Sanz A, Calvo C, Maluenda C, Westman P, de la Concha EG, Partanen J. 1998. HLA-DQ2-negative celiac disease in Finland and Spain. Hum. Immunol. 59:169-75
80. Clot F, Gianfrani C, Babron MC, Bouguerra F, Southwood S, Kagnoff MF, Troncone R, Percopo S, Eliaou JF, Clerget-Darpoux F, Sette A, Greco L. 1999. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics 49:800-7
81. O'Neill CM, Bunce M, Welsh KI. 1996. Detection of the DRB4 null gene, DRB4*0101102N, by PCR-SSP and its distinction from other DRB4 genes. Tissue Antigens 47:245-48
82. Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. 1992. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc. Natl. Acad. Sci. USA 89:3932-36
83. Powis SH, Rosenberg WM, Hall M, Mockridge I, Tonks S, Ivinson A, Ciclitira PJ, Jewell DP, Lanchbury JS, Bell JI, et al. 1993. TAP1 and TAP2 polymorphism in coeliac disease. Immunogenetics 38:345-50
84. Meddeb-Garnaoui A, Zeliszewski D, Mougenot JF, Djilali-Saiah I, Caillat-Zucman S, Dormoy A, Gaudebout C, Tongio MM, Baudon JJ, Sterkers G. 1995. Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum. Immunol. 43:190-99
85. Mazzilli MC, Ferrante P, Mariani P, Martone E, Petronzelli F, Triglione P, Bonamico M. 1992. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(α1*0501,β1*0201)heterodimer. Hum. Immunol. 33:133-39
86. Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha EG. 1995. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum. Immunol. 42:295-300
87. Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ, Wright DH. 1995. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum. Immunol. 43:29-37
88. McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. 1996. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur. J. Immunol. 26:2113-18
89. McManus R, Moloney M, Borton M, Finch A, Chuan YT, Lawlor E, Weir DG, Kelleher D. 1996. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum. Immunol. 45:24-31
90. Polvi A, Mäki M, Collin P, Partanen J. 1998. TNF microsatellite alleles a2 and b3 are not primarily associated with celiac disease in the Finnish population. Tissue Antigens 51:553-55
91. Lie BA, Sollid LM, Ascher H, Ek J, Akselsen HE, Rønningen KS, Thorsby E, Undlien DE. 1999. A gene telomeric of the HLA class I region is involved in predisposition to type 1 diabetes and coeliac disease. Tissue Antigens 54:162-68
92. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jorgensen K, Rønningen KS, Thorsby E, Undlien DE. 1999. The predisposition to type I diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64:793-800
93. Fodil N, Pellet P, Laloux L, Hauptmann G, Theodorou I, Bahram S. 1999. MICA haplotype diversity. Immunogenetics 49:557-60
94. Petersdorf EW, Schuler KB, Lanton GM, Spies T, Hansen JA. 1999. Population study of alleleic diversity of the human MHC class I-related MIC-A gene. Immunogenetics 49:605-12
95. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura S, Bahrain S, Inoko H. 1997. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc. Natl. Acad. Sci. USA 94:1298-1303
96. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177-82
97. Vartdal F, Johansen BH, Friede T, Thorpe C, Stevanovic S, Eriksen JA, Sletten K, Thorsby E, Rammensee HG, Sollid LM. 1996. The peptide binding motif of the disease associated HLA-DQ(α1*0501, β1*0201) molecule. Eur. J. Immunol. 26:2764-72
98. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule. Immunogenetics 44:246-53
99. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Papadopoulos GK, Koning F. 1997. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule. Immunogenetics 46:484-92
100. Quarsten H, Paulsen G, Johansen BH, Thorpe CJ, Holm A, Buus S, Sollid LM. 1998. The P9 pocket of HLA-DQ2 (non-Aspβ57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspβ57 MHC class II molecules. Int. Immunol. 10:1229-36
101. Rammensee HG, Friede T, Stevanovic S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
102. Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D, Hill A, Rammensee HG. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9:905-11
103. Kwok WW, Domeier ML, Raymond FC, Byers P, Nepom GT. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171-77
104. Khalil-Daher I, Boisgerault F, Feugeas JP, Tieng V, Toubert A, Charron D. 1998. Naturally processed peptides from HLA-DQ7 (α1*0501-β1*0301): influence of both α and β chain polymorphism in the HLA-DQ peptide binding specificity. Eur. J. Immunol. 28:3840-49
105. Quarsten H, Molberg Ø, Fugger L, McAdam SN, Sollid LM. 1999. HLA binding and T cell recognition of a tissue transglutaminase modified gliadin epitope. Eur. J. Immunol. 29:2506-14
106. Halstensen TS, Scott H, Fausa O, Brandtzaeg P. 1993. Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4 + T cells and macrophages but no crypt-cell hyperplasia. Scand. J. Immunol. 38:581-90
107. Lundin KEA, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. 1993. Gliadin-specific, HLA-DQ(α1*0501,β1*0201)restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178:187-96
108. Molberg Ø, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KEA. 1997. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46:103-9
109. Molberg Ø, Lundin KEA, Nilsen EM, Scott H, Kett K, Brandtzaeg P, Thorsby E, Sollid LM. 1998. HLA restriction patterns of gliadin-and astrovirus-specific CD4 + T cells isolated in parallel from the small intestine of celiac disease patients. Tissue Antigens 52:407-15
110. Lundin KEA, Gjertsen HA, Scott H, Sollid LM, Thorsby E. 1994. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum. Immunol. 41:24-27
111. Lundin KEA, Scott H, Fausa O, Thorsby E, Sollid LM. 1994. T cells from the small intestinal mucosa of a DR4, DQ7/ DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41:285-91
112. Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KEA. 1994. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand. J. Immunol. 39:567-74
113. Nilsen EM, Lundin KEA, Krajci P, Scott H, Sollid LM, Brandtzaeg P. 1995. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766-76
114. van de Kamer JH, Weijers HA, Dicke WK. 1953. Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr. 42:223-31
115. Shewry PR, Tatham AS, Kasarda DD. 1992. Cereal proteins and coeliac disease. In Coeliac Disease, ed. M Marsh, pp. 305-48. Oxford: Blackwell
116. Anderson OD, Litts JC, Greene FC. 1997. The α-gliadin gene family. I. Characterization of ten new wheat α-gliadin genomic clones, evidence for limited sequence conservation of flanking DNA, and Southern analysis of the gene family. Theor. Appl. Genet. 95:50-58
117. Lundin KEA, Sollid LM, Norén O, Anthonsen D, Molberg Ø, Thorsby E, Sjöström H. 1997. Heterogenous reactivity patterns of HLA-DQ-restricted small intestinal T-cell clones from patients with celiac disease. Gastroenterology 112: 752-59
118. Sjöström H, Lundin KEA, Molberg Ø, Körner R, McAdam SN, Anthonsen D, Quarsten H, Norén O, Roepstorff P, Thorsby E, Sollid LM. 1998. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48:111-15
119. Arentz-Hansen EH, Körner R, Quarsten H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM, McAdam S. 1999. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Submitted
120. van de Wal Y, Kooy YM, van Veelen PA, Peña SA, Mearin LM, Molberg Ø, Lundin KEA, Sollid LM, Mutis T, Benckhuijsen WE, Drijfhout JW, Koning F. 1998. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. USA 95:10050-54
121. van de Wal Y, Kooy YMC, van Veelen P, Vader W, August SA, Drijfhout JW, Peña SA, Koning F. 1999. Glutenin is involved in the gluten-driven mucosal T cell response. Eur. J. Immunol. In press
122. van de Wal Y, Kooy Y, van Veelen P, Peña S, Mearin L, Papadopoulos G, Koning F. 1998. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161:1585-88
123. Molberg Ø, McAdam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Roepstorff P, Lundin KEA, Sjöström H, Sollid LM. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells. Nat. Med. 4:713-17
124. Bnice SE, Bjarnason I, Peters TJ. 1985. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin. Sci. 68:573-79
125. Aeschlimann D, Paulsson M. 1994. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb. Haemost. 71:402-15
126. Folk JE. 1983. Mechanism and basis for specificity of transglutaminase-catalyzed ε-(γ-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol. 54:1-56
127. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203-8
128. Perry LL, Barzaga ME. 1987. Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J. Immunol. 138: 1434-41
129. McCarron RM, Fallis RJ, McFarlin DE. 1990. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73-79
130. Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E. 1994. T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ(α1*0501, β1*0201) heterodimer. Hum. Immunol. 39:243-52
131. Sturgess R, Day P, Ellis HJ, Lundin KEA, Gjertsen HA, Kontakou M, Ciclitira PJ. 1994. Wheat peptide challenge in coeliac disease. Lancet 343:758-61
132. Hällström O. 1989. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 30:1225-32
133. Sollid LM, Molberg Ø, McAdam S, Lundin KEA. 1997. Autoantibodies in coeliac disease: tissue transglutaminase -guilt by association? Gut 41:851-52
134. Lake P, Mitchison NA. 1977. Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harbor Symp. Quant. Biol. 41:589-95
135. Garside P, Mowat AM, Khoruts A. 1999. Oral tolerance in disease. Gut 44:137-42
136. Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. 1998. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8:667-73
137. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. 1997. A major role for matrix metallo-proteinases in T cell injury in the gut. J. Immunol. 158:1582-90
138. Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, Londei M, Auricchio S. 1996. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 110:1368-78
139. Maiuri L, Auricchio S, Coletta S, De Marco G, Picarelli A, Di Tola M, Quaratino S, Londei M. 1998. Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology 115:564-72
140. Deem RL, Shanahan F, Targan SR. 1991. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin. Exp. Immunol. 83:79-84
141. Halttunen T, Mäki M. 1999. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 116:566-72
142. Nunes I, Gleizes PE, Metz CN, Rifkin DB. 1997. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 136:1151-63
143. Bonewald LF. 1999. Regulation and regulatory activities of transforming growth factor ß. Crit. Rev. Eukaryo. Gene Expr. 9:33-44
144. Letterio JJ, Roberts AB. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137-61
145. Verderio E, Nicholas B, Gross S, Griffin M. 1998. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp. Cell Res. 239:119-38
146. Sollid LM, Scott H. 1998. New tool to predict celiac disease on its way to the clinics. Gastroenterology 115:1584-86